CMIC GROUP

ABOUT CMIC GROUP

CMIC was founded in 1992 as the first contract research organization (CRO) in Japan. To enable pharmaceutical companies to develop better medicine sooner, we expanded our solutions to include contract development and manufacturing (CDMO), site support, and market solutions, supporting global companies to bring highly desired treatments to the Japanese market, to consult and conduct Asia clinical trials, or to bridge drug development and manufacturing needs between the US and Japan.

CMIC recently started a new stage by entering the healthcare arena. Leveraging our vast experience and expertise in the medical industry, we offer solutions using a new ecosystem of healthcare to support the individuals and local governments.

We strive to be a Personal Health Value Creator (PHVC) to meet our global customers’ needs in the U.S., Japan, and broader Asia.

FEATURED ARTICLES

Real-World Data: Digitalizing A Patient’s Prescription Journey In Japan

Explore how Japan’s healthcare system provides the most comprehensive RWD by giving access to the complete patient journey through both in- and out-of-hospital pharmacy records as well as personal health records.
How To Run Successful Clinical Trials In Japan

Read about why there is no longer any excuse not to include Japan as an integral part of any global clinical-development program for either pharmaceuticals or medical devices.
How The Fast-Changing R&D Pipeline Is Amplifying The Importance Of Adaptable CROs

Find out how major advances in the understanding of the causes of once-untreatable diseases have reshaped the global drug development pipeline over the past decade, paving the way for better health outcomes for many millions of people.
Tailoring Bioanalytical Testing In A New Era Of Drug Development

Learn why pharmaceutical companies have to perform a comprehensive battery of tests to ensure product quality, safety, efficacy, purity, and stability through qualitative and quantitative characterization.
Survey Results: Evolving Trends Of Decentralized Clinical Trials In Japan

Learn about the decentralized clinical trial initiatives and the trend in Japan, based on the survey CMIC conducted targeting pharmaceutical companies.
The Emergence Of Digital Therapeutics: Building A Future

Over time, explore how the data collected by digital therapeutics has the potential to unlock predictive and diagnostic information that will enhance patient outcomes.
Gateways To Asia: Market Access In Japan And South Korea

Learn how the recent developments in market access and regulatory rules in Japan and South Korea have paved the way for expansion in Asia.
Another Look At The World’s Second-Largest Prescription Drug Market In A Post-Pandemic World

Read about why the pharma industry has compelling reasons to include Japan in clinical trials and the country’s responses to the COVID-19 pandemic have only furthered the country’s appeal to the rest of the pharma industry.
How Real-World Data Is Revolutionizing Rare Oncology Drug Development

Delve into the challenges and benefits associated with the use of real-world data in the oncology drug development process.
Non-Clinical Studies: The Foundations Of Successful Drug Development

Discover how using advanced techniques and analysis methods can predict what a drug candidate’s pharmacokinetic, efficacy, and safety profiles are likely to be in clinical trials.

Accelerating Clinical Development In The Asia-Pacific Region

Learn from industry experts on the market insights and tips for your successful clinical development in Japan and China.

Accelerating Clinical Development In Japan And China: Pricing, Inspection And Regulatory Trends

The APAC market has a large treatment naïve population, and has shown improvements in the regulatory environment. Discover insights and tips for successful clinical development in the APAC region

Contingency Planning For The Pharmaceutical Industry: How To Reduce Disruption, Downtime, And Profit Loss

The COVID-19 global pandemic took the world by storm, disrupting several industries and our global supply chains. Learn why having a contingency plan and proactively planning gives a company a competitive edge.

Current Trends In Oncology Development: How To Navigate Regulatory Hurdles And Accelerate Your Trials

Explore how to navigate the regulatory hurdles and accelerate oncology clinical trials by making the right connections within the oncology field.

Frontier Of mRNA Drug Discovery: Cancer treatment Using mRNA And Its Future Prospects

Explore why mRNA therapeutics has already become a focus area with joint efforts from pharmaceutical companies worldwide.

Prophylactic And Therapeutic Applications Of mRNA Technology For Infectious Diseases

In recent years, attempts to utilize messenger RNA (mRNA) for medicines are actively increasing worldwide. Since mRNA can produce any protein in theory, it is expected to have a wide range of clinical applications.

More Webinars

CONTACT INFORMATION

CMIC Group

Hamamatsucho Building, 1 Chome-1-1 Shibaura

Minato City, Tokyo, 105-0023

JAPAN

Contact: inquiriesUSA@cmicgroup.com

Request More Information

Visit Our Website

FEATURED SOLUTIONS

Cell & Gene Therapy Solutions: Basic Research To Practical Applications

Discover CMIC's services from basic research to practical applications in the cell and gene landscape.
Medical Device And In Vitro Diagnostic Consulting And CRO Services

As the largest CRO in Japan CMIC Group provides end-to-end solutions for medical devices & in vitro diagnostics in the U.S., Europe, Japan and most of Asia.
Asia-Pacific Drug Development Solutions

Discover the ways CMIC Group supports your drug development journey with a strong Asian presence.
Early Phase Clinical Trial Solutions

Relying on vast expertise and experience, we work with biotechs looking to take advantage of the benefits of early development in Japan and Asia-Pacific region, and tailor our early phase clinical trial platform to meet your development needs.
Unlocking The Power Of Real World Data Related Services

CMIC provides high quality services in accordance with your request, from research planning, statistical analysis to report preparation.
Digital Transformation Of Patient Support Program

Considering improvement of patients’ QOL with high-quality digitalized treatment support tools? CMIC is offering DX solutions to support the patient journey.
On Top Of Oncology Drug Development Trends

Our team has an average of 10+ years of oncology experience and strong relationships with KOLs throughout Japan and Asia, allowing them to be on top of oncology trends.
CMIC Group Services Overview

Discover CMIC Group's history and list of services in the available brochure.
Offering Biotechs Agile Access To The World's Major Pharmaceutical Markets

Leverage CMIC's vast experience and expertise in the medical industry with solutions that use a new ecosystem of healthcare to support individuals and local governments.